ClinicalTrials.govpublic full text
Liposomal Amikacin for Inhalation (LAI) for Nontuberculous Mycobacteria
mycobacterium infections, nontuberculous, amikacin liposome inhalation suspension (alis), arikayce, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 912328
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.